Given the frequency and persistence of human papillomavirus (HPV) infection and associated cytological alterations in HIV-1-positive women, the incidence of uterine cervix neoplasm is likely to increase along with patient survival. More appropriate screening programs, which, in addition to Pap smear
Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples
✍ Scribed by Hesselink, Albertus T. ;van den Brule, Adriaan J. C. ;Brink, Antoinette A. T. P. ;Berkhof, Johannes ;van Kemenade, Folkert J. ;Verheijen, René H. M. ;Snijders, Peter J. F.
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 426 KB
- Volume
- 102
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
The authors thank Prof. C. J. L. M. Meijer for his continuous support. They are grateful to Mr. B. Bakker, Mrs. T. Tadema, Mrs. N. Fransen Daalmeijer, and Mrs. P. van Diemen for excellent technical assistance. Coated slides for liquid-based cytology were kindly provided by Ventana Medical Systems. Sample Conversion Kits and Hybrid Capture 2 testing kits were kindly provided by Digene Corporation.
📜 SIMILAR VOLUMES
## Abstract To test the reliability of the Hybrid Capture II (HC‐II) assay detecting 13 high‐risk human papillomavirus (HR‐HPV) types for the screening of cervical lesions, we monitored by cytology, HR‐HPV testing, colposcopy and biopsy, 3,091 women with normal smears at the first entry. Our primar
We assessed the detection of high-risk human papillomavirus DNA (HPV-DNA) in women examined by a second Pap smear due to atypical glandular cells (AGC) detected in their screening Pap smear. In 91 women included in the study, a second Pap smear was taken and HPV-DNA test was performed using Hybrid C
## Abstract The PapilloCheck® assay was compared with the Digene HC2 HPV DNA assay for the detection of 13 high‐risk human papillomaviruses (HPV) in 240 samples, including 181 cervical scrapes and 59 anal scrapes. Overall, 75 (30.5%) samples were positive by the Digene HC2 HPV DNA assay: 34 (18.8%)